Key facts
- It has raised $25.4M; the latest was Early Stage VC ($17.0M) in Dec 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Yiyuantang Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Yiyuantang Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yiyuantang Pharmaceutical
Manufacturer of pharmaceutical products intended to advance drug development through integrated chemical and biological technologies. The company offers proprietary enzyme catalysis, advanced flow chemistry, and high-potency manufacturing capabilities, enabling biopharma and biotech companies to accelerate clinical timelines, reduce environmental impact, and enhance production efficiency.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Yiyuantang Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yiyuantang Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yiyuantang Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.